These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15199039)

  • 1. Using pharmacogenetics to improve drug safety and efficacy.
    Haga SB; Burke W
    JAMA; 2004 Jun; 291(23):2869-71. PubMed ID: 15199039
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenetic study of statin therapy and cholesterol reduction.
    Marian AJ
    Curr Atheroscler Rep; 2005 May; 7(3):177-8. PubMed ID: 15811249
    [No Abstract]   [Full Text] [Related]  

  • 3. Statins personalized.
    Superko HR; Momary KM; Li Y
    Med Clin North Am; 2012 Jan; 96(1):123-39. PubMed ID: 22391257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
    Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
    Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Children Are Not Small Adults: Specific Findings in Statin Exposure and Response in a Growing Population.
    Wagner JB
    Clin Pharmacol Ther; 2019 Aug; 106(2):278-280. PubMed ID: 30970165
    [No Abstract]   [Full Text] [Related]  

  • 6. [Xenobiotic-metabolizing polymorphic enzymes. An opportunity for individualized drug treatment].
    Lhermitte M; Allorge D; Broly F
    Bull Acad Natl Med; 2006 Jan; 190(1):55-69; discussion 69-73. PubMed ID: 16878446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity due to 6-thioquanine.
    Gözdaşoğlu S
    Pediatr Blood Cancer; 2005 Nov; 45(6):867; author reply 868. PubMed ID: 16047370
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
    Schwab M; Herrlinger K; Schaeffeler E; Stange EF
    Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD.
    Seidman EG
    Rev Gastroenterol Disord; 2003; 3 Suppl 1():S30-8. PubMed ID: 12684587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of statin intolerance.
    Suthers G; Somogyi AA
    Intern Med J; 2020 Apr; 50(4):506-507. PubMed ID: 32270606
    [No Abstract]   [Full Text] [Related]  

  • 11. Review article: thiopurines in inflammatory bowel disease.
    Derijks LJ; Gilissen LP; Hooymans PM; Hommes DW
    Aliment Pharmacol Ther; 2006 Sep; 24(5):715-29. PubMed ID: 16918876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing toxicity with a gene test.
    Marshall E
    Science; 2003 Oct; 302(5645):588-90. PubMed ID: 14576416
    [No Abstract]   [Full Text] [Related]  

  • 13. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.
    Karas-Kuzelicki N; Mlinaric-Rascan I
    Pharmacogenomics; 2009 Aug; 10(8):1309-22. PubMed ID: 19663675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: clinical use of biomarkers in drug metabolism and adverse drug reactions.
    Agundez JA
    Curr Drug Metab; 2014 Feb; 15(2):127-8. PubMed ID: 24655066
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenetics of drugs withdrawn from the market.
    Zhang W; Roederer MW; Chen WQ; Fan L; Zhou HH
    Pharmacogenomics; 2012 Jan; 13(2):223-31. PubMed ID: 22256871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacogenetics and prediction of side effects of drugs].
    Harrak M; Khabbal Y; Amarti A; El Hassouni M; Ouldim K
    Ann Biol Clin (Paris); 2014; 72(4):405-12. PubMed ID: 25119798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene variant may help identify patients who benefit most from statins.
    Printz C
    Cancer; 2010 Sep; 116(17):3984. PubMed ID: 20803730
    [No Abstract]   [Full Text] [Related]  

  • 18. The future of thiopurine pharmacogenomics.
    Duley JA; Somogyi AA; Martin JH
    Pharmacogenomics; 2012 Nov; 13(14):1549-52. PubMed ID: 23148628
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacogenomics and drug toxicity.
    Nakamura Y
    N Engl J Med; 2008 Aug; 359(8):856-8. PubMed ID: 18650508
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics--tailoring treatment for the outliers.
    Woodcock J; Lesko LJ
    N Engl J Med; 2009 Feb; 360(8):811-3. PubMed ID: 19228625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.